Exchange: NASDAQ·Updated 07:30 PM EST
LSTA logo

LSTA Lisata Therapeutics Inc

$1.01
$0.01
(0.98%)
Today
Closed $1.01
$0.00
(0.00%)
After Hours
EarningsNov 5
Mkt Cap$11.02M
Vol97,148.00

About LSTA

Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
46

Neutral Sentiment

How do you feel about LSTA?

Biotech_Pharma_Investor
$LSTA Is this getting cheap again?? Not as simple a set-up as before. But the merged company will be a very decent company with great assets and runway through 2028. Funding at $1.49 ($225M).
2
bulmar
$LSTA Ince I saw retail claiming to own a large portion of this stock near 2 bucks I was like run away..
ikkydiphoenix
$LSTA kuva's original offer was over 6 simes higher than now. I find it hard to believe that the new offer they made was lower than 1$ so it looks like CEO is once again actain against shareholders best interests. I think Marea shareholders should be worried to merge business with Mr. Mazzo.
longshot45
$LSTA 52 week low appears to be holding… for now. The precipitous drop however gives me the feeling we’re going to see the floor break sometime this week
Biotech_Pharma_Investor
$LSTA Could it be that this going down due to the planned RS for the merger?? (silly if yes)
SQUEAKSBANDIT
$LSTA what a frikkin bust hope you sucker buyers didn't pay 1.50 for these toxic shares 2.5% of the new company !!! ahhhhhhhhh
Stock_Catcher
$LSTA Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
TwongStocks
$LSTA Preliminary proxy for shareholder meeting scheduled Nov 9 https://www.sec.gov/ix?doc=/Archives/edgar/data/320017/000114036126038937/ny20082391x1_pre14a.htm Shareholders are being asked to: 1) Elect Cynthia Flowers and Ted Love as Directors 2) Ratify Grant Thornton LLP as independent auditor 3) Approve the Series C Non-Voting Convertible Preferred Stock issued as part of the Marea acquisition & PIPE. 4) Approve a reverse split in the range of 1:5 to 1:10. 5) Approve the 2026 Equity Incentive Plan 6) Approve the 2026 ESPP 7) Approve executive compensation. Non-binding "say on pay" 8) Approve an adjournment if they do not have enough votes to pass Proposals 3-6.
SQUEAKSBANDIT
$LSTA not too much to say at this point sub 1 plus a r/s almost a certainty just look at the history here scammy, and may be close to the record for name changes over time

Advertisement|Remove ads.